Revenio Group Oyj (LON:0KFH)

Market Cap	645.32M
Revenue (ttm)	88.94M
Net Income (ttm)	15.98M
Shares Out	n/a
EPS (ttm)	0.60
PE Ratio	40.39
Forward PE	31.61
Dividend	0.35 (1.25%)
Ex-Dividend Date	Apr 11, 2025

Volume	1,702
Average Volume	851
Open	27.75
Previous Close	n/a
Day's Range	27.71 - 27.75
52-Week Range	22.40 - 35.74
Beta	1.38
RSI	56.12
Earnings Date	Aug 7, 2025

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for mea...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2001
• Employees: 241
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KFH

Financial Performance

In 2024, Revenio Group Oyj's revenue was 103.82 million, an increase of 7.27% compared to the previous year's 96.79 million. Earnings were 18.50 million, a decrease of -3.20%.

Financial numbers in EUR